Next Generation Sequencing Minimal Residual Disease in Pediatric B-ALL after CD19 and/or CD22 CAR T-cell Therapy: Depth and Kinetics of Response Predict Relapse Risk.

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Lucy E. Cain, Yimei Li, Hongyan Liu, Regina M. Myers, Allison Barz Leahy, Diane Baniewicz, Colleen A. Callahan, Amanda M. DiNofia, Caroline J. Diorio, Stephen P. Hunger, Kaylyn Utley Lyons, Susan McClory
+6 more Susan R. Rheingold, Mackenzie Stewart, Sarah K Tasian, Lisa Wray, Stephan A. Grupp, Shannon L. Maude
DOI: 10.1016/j.jtct.2025.12.163
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Acute Lymphoblastic Leukemia research Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S112–S113
Publication date
1 February 2026
Language
EN